Sulfur Hexafluoride Lipid-type A Microspheres Patent Expiration
Sulfur Hexafluoride Lipid-Type A Microspheres is Used for characterizing focal liver lesions with ultrasound in both adult and pediatric patients. It was first introduced by Bracco Diagnostics Inc
Sulfur Hexafluoride Lipid-type A Microspheres Patents
Given below is the list of patents protecting Sulfur Hexafluoride Lipid-type A Microspheres, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lumason | US11723869 | Freeze-dried product and gas-filled microvesicles suspension | May 15, 2039 | Bracco |
| Lumason | US10232061 | Freeze-dried formulation for gas-filled microvesicles | Jul 06, 2038 | Bracco |
| Lumason | US10335502 | Freeze-dried formulation for gas-filled microvesicles | Jul 06, 2038 | Bracco |
| Lumason | US5686060 | Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography |
Nov 11, 2019
(Expired) | Bracco |
Sulfur Hexafluoride Lipid-type A Microspheres's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List